Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cary O Harding

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Pediatrics|June 15, 2011
Siblings with mitochondrial acetoacetyl-CoA thiolase deficiency not identified by newborn screeningKyriakie Sarafoglou, Dietrich Matern, Krista Redlinger-Grosse, et al.
Molecular Genetics and Metabolism|June 18, 2003
Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiencyMelanie B Gillingham, William E Connor, Dietrich Matern, et al.
Molecular Genetics and Metabolism|March 6, 2025
D-BHB supplementation before moderate-intensity exercise suppresses lipolysis and selectively blunts exercise-induced long-chain acylcarnitine increase in pilot study of patients with long-chain fatty acid oxidation disordersAshley N Gregor, Philippe Delerive, Bernard Cuenoud, et al.
Molecular Genetics and Metabolism|October 14, 2020
A novel Pah-exon1 deleted murine model of phenylalanine hydroxylase (PAH) deficiencyDaelyn Y Richards, Shelley R Winn, Sandra Dudley, et al.
Journal of Inherited Metabolic Disease|July 12, 2019
Higher dietary protein intake preserves lean body mass, lowers liver lipid deposition, and maintains metabolic control in participants with long-chain fatty acid oxidation disordersMelanie B Gillingham, Gabriela Elizondo, Annie Behrend, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 24, 2025
Long-term management strategies for pegvaliase use in phenylketonuria: Lessons learned from the phase-3 PRISM open-label extension studyCary O Harding, Kaleigh Bulloch Whitehall, Joshua Lilienstein, et al.
Molecular Therapy. Nucleic Acids|September 17, 2014
A sensitive assay system to test antisense oligonucleotides for splice suppression therapy in the mouse liverLorena Gallego-Villar, Hiu Man Viecelli, Belén Pérez, et al.
Molecular Genetics and Metabolism|January 15, 2018
Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric miceShelley R Winn, Tanja Scherer, Beat Thöny, et al.
Molecular Therapy. Methods & Clinical Development|January 24, 2020
AAV-Mediated CRISPR/Cas9 Gene Editing in Murine PhenylketonuriaDaelyn Y Richards, Shelley R Winn, Sandra Dudley, et al.
Journal of Inherited Metabolic Disease|January 15, 2021
Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglycerideGaren Gaston, Jon A Gangoiti, Shelley Winn, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Pediatrics|June 15, 2011
Siblings with mitochondrial acetoacetyl-CoA thiolase deficiency not identified by newborn screeningKyriakie Sarafoglou, Dietrich Matern, Krista Redlinger-Grosse, et al.
Molecular Genetics and Metabolism|June 18, 2003
Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiencyMelanie B Gillingham, William E Connor, Dietrich Matern, et al.
Molecular Genetics and Metabolism|March 6, 2025
D-BHB supplementation before moderate-intensity exercise suppresses lipolysis and selectively blunts exercise-induced long-chain acylcarnitine increase in pilot study of patients with long-chain fatty acid oxidation disordersAshley N Gregor, Philippe Delerive, Bernard Cuenoud, et al.
Molecular Genetics and Metabolism|October 14, 2020
A novel Pah-exon1 deleted murine model of phenylalanine hydroxylase (PAH) deficiencyDaelyn Y Richards, Shelley R Winn, Sandra Dudley, et al.
Journal of Inherited Metabolic Disease|July 12, 2019
Higher dietary protein intake preserves lean body mass, lowers liver lipid deposition, and maintains metabolic control in participants with long-chain fatty acid oxidation disordersMelanie B Gillingham, Gabriela Elizondo, Annie Behrend, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 24, 2025
Long-term management strategies for pegvaliase use in phenylketonuria: Lessons learned from the phase-3 PRISM open-label extension studyCary O Harding, Kaleigh Bulloch Whitehall, Joshua Lilienstein, et al.
Molecular Therapy. Nucleic Acids|September 17, 2014
A sensitive assay system to test antisense oligonucleotides for splice suppression therapy in the mouse liverLorena Gallego-Villar, Hiu Man Viecelli, Belén Pérez, et al.
Molecular Genetics and Metabolism|January 15, 2018
Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric miceShelley R Winn, Tanja Scherer, Beat Thöny, et al.
Molecular Therapy. Methods & Clinical Development|January 24, 2020
AAV-Mediated CRISPR/Cas9 Gene Editing in Murine PhenylketonuriaDaelyn Y Richards, Shelley R Winn, Sandra Dudley, et al.
Journal of Inherited Metabolic Disease|January 15, 2021
Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglycerideGaren Gaston, Jon A Gangoiti, Shelley Winn, et al.
Pageof 12